Williams B T, Park J H, Yamamoto T. "一种奥希替尼杂质107的合成方法" [P]. US Patent, US 9002680 B2, 2023-09-01.
发明人杨光,韩伟,冯建国. "Method for the Synthesis of Osimertinib Impurity 107" [P]. 中国发明专利, 专利号 CN 113113002 A, 授权公告日 2024-01-17.
发明人李文辉,钱学锋,张德明. "A Process for Preparing High-Purity Osimertinib Impurity 107" [P]. 中国发明专利, 专利号 CN 108725422 A, 授权公告日 2021-03-10.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 奥希替尼杂质107 in Pharmaceutical Formulations". Chromatographia, 2017, 1180, (11), 4144-4152.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥希替尼杂质107 as an Impurity". Anal. Chem., 2013, 998, (7), 9566-9591.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Osimertinib Impurity 107 Using HRMS and NMR". J. Agric. Food Chem., 2023, 986, (8), 2213-2227.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 奥希替尼杂质107 Profile in Drug Substances According to ICH Guidelines". Talanta, 2013, 1229, (7), 1523-1535.